维普中文期刊产品整合服务
124篇 您的检索式:作者名="Cole BF"
    题名 作者 年代 出处 被引量
1Polymorphisms in glutathione S-transferases (GSTM1 and GSTT1) and survival after treatment for breast cancer 显示文摘Ambrosone CB Sweeney C Coles BF 2001Cancer Res2001,61,19:1
2Classical cyclophos- phamide, methotrexate, and fluorouracil chemotherapy is more effective in triple-negative, node-negative breast can- cer: resuhs from two randomized trials of adjuvant chemoen- docrine therapy for node-negative breast cancer显示文摘Colleoni M Cole BF Viale G 2010J Clin Oncol2010,28,18:1
3Novel markers of susceptibility to carcinogens in diet: associations with colorectal cancer显示文摘Sweeney C Coles BF Nowell S Lang NP Kadlubar FF 2002Toxicology2002,18,:1
4A randomized trial of aspirin to prevent colorectal adenomas显示文摘Baron JA Cole BF Sandler RS 0,,10:1
5Quantitative analysis of interindividual variation of glutathione S-transferase expression in human pancreas and the ambiguity of correlating genotype with phenotype显示文摘Coles BF Anderson KE Doerge DR 2000Cancer Res2000,60,3:1
6Axillary dissection versus no axillary dissection in patients with sentinel-node micrometastases (IBCSG 23-01 ) :a phase 3 randomised controlled trial 显示文摘Galimberti V Cole BF Zurrida S 2013Lancet Oneol2013,14,:1
7Axillary dissection versus no axillary dissection in patients with sentinel-node micrometastases (IBCSG 23-01):a phase 3 randomised controlled trial显示文摘Galimbei V Cole BF Zurrida S 2013Lancet Oncol2013,14,4:1
8Pharmacokinetic-pharmaxodynamic relationships of the bispecific antibody MDX-210 when administered in combination with interferon gamma:a multiple-dose phase-Ⅰ study in patients with advanced cancer which overexpresses HER-2/neu显示文摘Lewis LD Cole BF Wallace PK 2001J Immunol Methods2001,248,12:1
9The opportunistic pathogen Toxoplasma gondii deploys a diverse legion of invasion and survival proteins显示文摘Zhou XW Kafsack BF Cole RN 0,,40:1
10Classical cyclophosphamide,methotrexate,and fluorouracil chemotherapy is more effective in triple-negative,nodenegative breast cancer:results from two randomized trials of adjuvant chemoendocrine therapy for node-negative breast cancer显示文摘Colleoni M Cole BF Viale G 2010J Clin Oncol2010,28,18:1
11Axillary dissection versus no axillary dissection in patients with sentinel-node micrometastases(IBCSG 23-01):a phase 3 randomised controlled trial显示文摘Galimberti V Cole BF Zurrida S 2013Lancet Oncol2013,14,4:1
12Axillary dissection versus no axillary dissection in patients with sentinel-node micrometastases(IBCSG 23-01):a phase 3 randomised controlled trial显示文摘Galimberti V Cole BF Zurrida S 2013Lancet Oncol2013,14,4:1
13Axillary dissection versus no axillary dissection in patients with sentinel-node micrometastases ( IBCSG 23-01 ) : a phase 3 randomised controlled trial显示文摘Galimberti V Cole BF Zurrida S 2013Lancet Oncol2013,,4:1
14Cerebsrospinal fluid cytology in patients with cancer:minimizing false-negative result显示文摘Glantz MJ Cole BF Glantz LK 1998Cancer1998,82,4:1
15Cerebrospinal fluid cytology in patients with cancer, minimizing false - negative results 显示文摘Glantz M J Cole BF Giantz LK 1998Cancer1998,82,:1
16Cerebrospinal fluid cytology in patients with cancer miniminzing false-negative results显示文摘Glantz M J Cole BF Glantz LK 1998Cancer1998,82,:1
17Symptoms of endocrine treatment and outcome in the BIG 1-98 study 显示文摘Huober J Cole BF Rabaglio M 2014Breast Cancer ResTreat2014,143,1:1
18Axillary dissection versus no axillary dissection in patients with sentinel-nodemicrometastases (IBCSG 23-01 ): a phase 3 randomised controlled trial 显示文摘Galimberti V Cole BF Zurrida S 2013Lancet Oneo12013,14,4:1
19Cerebrospinal fluid cytology in paients with cancer:minimizing false negative results显示文摘Glantz MJ Cole BF Glantz LK 1998Cancer1998,82,4:1
20Detoxification of electrophilic compounds by glutathione S-transferase catalysis:determinants of individual response to chemical carcinogens and chemotherapeutic drugs? 显示文摘Coles BF Kadlubar FF 2003Bio{actors2003,17,14:1
返回顶部 每页显示:
共7页 首页 上一页 第1页 下一页 末页 /7 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费